| JP2000044468 |
Anti-obesity agent due to lipase inhibitory effect |
[43] |
| EP1254209 |
Garcinol along with hydoxycitric acid and anthocyanins- cyanidine-3-glucoside & cyanidine-3-sambubioside, is effective in reducing total body weight, body fat and increasing the lean body mass |
[44] |
| US20090062231 |
A composition containing garcinol along with alginate and hydroxycitric acid used as appetite suppressant which not only claim to reduce total cholesterol, triglycerides, glucose but also inhibits gastric reflux |
[45] |
| US8329743 |
Composition along with other phytoconstituents reduces adipogenesis and hence is useful in treating obesity |
[46] |
| US20130281544 |
Hepatoprotective agent showing in vitro and in vivo activity |
[47] |
| WO2016123044 |
Treatment of endometriosis |
[48] |
| US9872840 |
Treatment of renal disorders specifically for diabetic nephropathy |
[49] |
| WO2016063296 |
Derivatives of garcinol, acting as p-glycoprotein inducers, as therapeutic agents for treatment of Alzheimer’s |
[50] |
| US9956301 |
Garcinol complexed with cyclodextrin used in prevention and management of cardiac dysfunction induced by chemotherapy or lifestyle/disease conditions |
[51] |
